The molecular basis of activity-induced muscle injury in Duchenne muscular dystrophy

Molecular and Cellular Biochemistry

Volumn 179, Issue 1-2, 1998, Pages 111-124

  Petrof, Basil J ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Diaphragm; Duchenne muscular dystrophy; Dystrophin; Exercise; Plasma membrane; Respiratory muscle contraction; Sarcolemma

Indexed keywords

CELL SURFACE PROTEIN; DYSTROGLYCAN; DYSTROPHIN; MEMBRANE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BREATHING MUSCLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DIAPHRAGM; DUCHENNE MUSCULAR DYSTROPHY; HUMAN; HUMAN TISSUE; MALE; MEMBRANE DAMAGE; MUSCLE CELL; MUSCLE CONTRACTION; MUSCLE DISEASE; MUSCLE FORCE; MUSCLE INJURY; NONHUMAN; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; STRESS;

ANIMALIA;

EID: 0031908112     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006812004945     Document Type: Review

References (93)

1. Smith PEM, Calverley PMA, Edwards RHT, Evans GA, Campbell EJM: Practical problems in the respiratory care of patients with muscular dystrophy. N Engl J Med 316: 1197-1204, 1987
2. Hoffman EP, Brown RHJ, Kunkel LM: Dysin: The protein product of the Duchenne muscular dystrophy locus. Cell 51: 919-928, 1987
3. Ahn AH, Kunkel LM: The structural and functional diversity of dystrophin. Nature Gene 3: 283-291, 1993
4. Love DR, Byth BC, Tinsley JM, Blake DJ, Davies KE: Dystrophin and dystrophin-related proteins: A review of protein and RNA studies. Neuromusc Disord 3: 5-21, 1993
5. Lidov HGW, Selig S, Kunkel LM: Dpl1140: A novel 140 kDa CNS transcript from the dystrophin locus. Hum Mol Genet 4: 329-335, 1995
6. D'Souza VN, Man NT, Morris GE, Karges W, Pillers D-AM, Ray PN: A novel dystrophin isoform is required for normal retinal electrophysiology. Hum Mol Genet 4: 837-842, 1995
7. Ohlendieck K, Campbell KP: Dystrophin constitutes 5% of membrane cytoskeleton in skeletal muscle. FEBS Lett 283: 230-234, 1991
8. Ervasti JM, Campbell KP: Membrane organization of the dystrophinglycoprotein complex. Cell 66: 1121-1131, 1991
9. Ozawa E, Yoshida M, Suzuki A, Mizuno Y, Hagiwara Y, Noguchi S: Dystrophin-associated proteins in muscular dystrophy. Hum Mol Genet 4: 1711-1716, 1995
10. Worton R: Muscular dystrophies: Diseases of the dystrophin-glycoprotein complex. Science 270: 755-756, 1995
11. Tinsley JM, Blake DJ, Zuellig RA, Davies KE: Increasing complexity of the dystrophin-associated protein complex. Proc Natl Acad Sci USA 91: 8307-8313, 1994
12. Ohlendieck K, Campbell KP: Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J Cell Biol 115: 1685-1694, 1991
13. Ervasti JM, Ohlendieck K, Kahl SD, Gaver MG, Campbell KP: Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345: 315-319, 1990
14. Greenberg DS, Sunada Y, Campbell KP, Yaffe D, Nudel U: Exogenous Dp71 restores the levels of dystrophin associated proteins but does not alleviate muscle damage in mdx mice. Nature Gene 8: 340-344, 1994
15. Cox GA, Sunada Y, Campbell KP, Chamberlain JS: Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy. Nature Gene 8: 333-339, 1994
16. Hoffman EP: Dystrophin associated proteins fail in filling dystrophin's shoes. Nature Gene 8: 311-312, 1994
17. Carpenter S, Karpati G: Duchenne muscular dystrophy. Plasma membrane loss initiates muscle cell necrosis unless it is repaired. Brain 102: 147-161, 1979
18. Mokri B, Engel AG: Duchenne dystrophy: Electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber. Neurology 25: 1111-1120, 1975
19. Emery AEH: Muscle histology and creatine kinase levels in the foetus in Duchenne muscular dystrophy. Nature 266: 472-473, 1977
20. Mahoney MJ, Haseltine FP, Hobbins JC, Banker BQ, Caskey CT, Globus MS: Prenatal diagnosis on Duchenne's muscular dystrophy. N Engl J Med 297: 968-973, 1977
21. Turner PR, Westwood T, Regen CM, Steinhardt RA: Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice. Nature 335: 735-738, 1988
22. Turner PR, Fong P, Denetclaw WF, Steinhardt RA: Increased calcium influx in dystrophic muscle. J Cell Biol 115: 1701-1712, 1988
23. Fong P, Turner PR, Denetclaw WF, Steinhardt RA: Increased activity of calcium leak channels in myotubes of Duchenne human and mdx mouse origin. Science 250: 673-766, 1990
24. Franco AJ, Lansman JB: Calcium entry through stretch-inactivated ion channels in mdx myotubes. Nature 344: 670-673, 1990
25. Menke A, Jockusch H: Decreased osmotic stability of dystrophin-less muscle cells from the mdx mouse. Nature 349: 69-71, 1991
26. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL: Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA 90: 3710-3714, 1993
27. Brown SC, Lucy JA: Dystrophin as a mechanochemical transducer in skeletal muscle. Bioessays 15: 413-419, 1993
28. Street SF: Lateral transmission of tension in frog myofibers: a myofibrillar network and transverse cytoskeletal connections are possible transmitters. J Cell Physiol 114: 346-364, 1983
29. Brennan JE, Chao DS, Xia H, Aldape K, Bredt DS: Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 85: 743-752, 1995
30. Campanelli JT, Roberds SL, Campbell KP, Scheller RH: A role for dystrophin-associated glycoproteins and utrophin in agrin-induced AChR clustering. Cell 77: 663-674, 1994
31. Chasis JA, Agre P, Mohandas N: Decreased membrane mechanical stability and in vivo loss of surface area reflect spectrin deficiencies in hereditary spherocytosis. J Clin Invest 82: 617-623, 1988
32. Waugh RE, Agre P: Reductions of erythrocyte membrane viscoelastic coefficients reflect spectrin deficiencies in hereditary spherocytosis. J Clin Invest 81: 133-141, 1988
33. Pasternak C, Wong S, Elson EL: Mechanical function of dystrophin in muscle cells. J Cell Biol 128: 355-361, 1995
34. Stedman HH, Sweeney HL, Shrager JB, Maguire HC, Panettieri RA, Petrof B, Narusawa M, Leferovich JM, Sladky JT, Kelly AM: The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352: 536-539, 1991
35. Weller B, Karpati G, Carpenter S: Dystrophin-deficient mdx muscle fibers are preferentially vulnerable to necrosis induced by experimental lengthening contractions. J Neurol Sci 100: 9-13, 1990
36. McCully K, Giger U, Argov Z, Valentine B, Cooper B, Chance B, Bank W: Canine X-linked muscular dystrophy studied with in vivo phosphorus magnetic resonance spectroscopy. Muscle Nerve 14: 1091-1098, 1991
37. Sacco P, Jones DA, Dick JR, Vrbova G: Contractile properties and susceptibility to exercise-induced damage of normal and mdx mouse tibialis anterior muscle. Clin Sci 82: 227-236, 1992
38. McArdle A, Edwards RH, Jackson MJ: Effects of contractile activity on muscle damage in the dystrophin-deficient mdx mouse. Clin Sci 80: 367-371, 1991
39. Tidball JG, Salem G, Zernicke R: Site and mechanical conditions for failure of skeletal muscle in experimental strain injuries. J Appl Physiol 74: 1280-1286, 1993
40. McCully KK, Faulkner JA: Characteristics of lengthening contractions associated with injury to skeletal muscle fibers. J Appl Physiol 61: 293-299, 1986
41. Warren GL, Hayes DA, Lowe DA, Armstrong RB: Mechanical factors in the initiation of eccentric contraction-induced injury in rat soleus muscle. J Physiol 464: 457-475, 1993
42. Huxley AF, Peachey LD: The maximum length for contraction in vertebrate striated muscle. J Physiol 156: 150-165, 1961
43. Edman KAP, Reggiani C: Length-tension-velocity relationships studied in short consecutive segments of intact muscle fibres of the frog. In: Anonymous. Contractile Mechanisms in Muscle. Plenum, New York, 1984, pp 495-509
44. Morgan DL: New insights into the behavior of muscle during active lengthening. Biophys J 57: 209-221, 1990
45. Cecchik G, Bagni MA, Griffiths PJ, Ashley CC, Maeda Y: Detection of radial crossbridge force by lattice spacing changes in intact single muscle fibers. Science 250: 1409-1411, 1990
46. Pierobon-Bormioli S: Transverse sarcomere filamentous systems: Z- and M-cables. J Muscle Res Cell Motil 2: 401-413, 1981
47. Shear CR, Bloch RJ: Vinculin in subsarcolemmal densities in chicken skeletal muscle: Localization and relationship to intracellular and extracellular structures. J Cell Biol 101: 240-256, 1985
48. Pardo JV, Siliciano JD, Craig SW: A vinculin-containing cortical lattice in skeletal muscle: Transverse lattice elements ('costameres') mark sites of attachment between myofibrils and sarcolemma. Proc Natl Acad Sci USA 80: 1008-1012, 1983
49. Small V, Furst DO, Thornell LE: The cytoskeletal lattice of muscle cells. Eur J Biochem 208: 559-572, 1992
50. Porter GA, Dmytrenko GM, Winkelmann JC, Bloch RJ: Dystrophin colocalizes with beta-spectrin in distinct subsarcolemmal domains in mammalian skeletal muscle. J Cell Biol 117: 997-1005, 1992
51. Masuda T, Fujimaki N, Ozawa E, Ishikawa H: Confocal laser microscopy of dystrophin localization in guinea pig skeletal muscle fibers. J Cell Biol 119: 543-548, 1992
52. Samitt CE, Bonilla E: Immunocytochemical study of dystrophin at the myotendinous junction. Muscle Nerve 13: 493-500, 1990
53. Tidball JG, Law DJ: Dystrophin is required for normal thin filament-membrane associations at myotendinous junctions. Am J Pathol 138: 17-21, 1991
54. Armstrong RB: Initial events in exercise-induced muscular injury. Med Sci Sports Exer 22: 429-435, 1990
55. Wilcox P, Osborne S, Bressler B: Monocyte inflammatory mediators impair in vitro hamster diaphragm contractility. Am Rev Respir Dis 146(2): 462-466, 1992
56. DiMario J, Strohman RC: Satellite cells from dystrophic (mdx) mouse muscle are stimulated by fibroblast growth factor in vitro. Differentiation. 39: 42-49, 1988
57. DiMario J, Buffinger N, Yamada S, Strohman RC: Fibroblast growth factor in the extracellular matrix of dystrophic (mdx) mouse muscle. Science 244: 688-690, 1989
58. Bernasconi P, Torchiana E, Confalonieri P, Brugnoni R, Barresi R, Mora M, Cornelio F, Morandi L, Mantegazza R: Expression of transforming growth factor-b1 in dystrophic patient muscles correlates with fibrosis. J Clin Invest 96: 1137-1144, 1995
59. Webster C, Blau HM: Accelerated age-related decline in replicative life-span of Duchenne muscular dystrophy myoblasts: Implications for cell and gene therapy. Somat Cell Mol Genet 16: 557-565, 1990
60. Petrof BJ, Stedman HH, Shrager JB, Eby J, Sweeney HL, Kelly AM: Adaptations in myosin heavy chain expression and contractile function in the dystrophic (MDX) mouse diaphragm. Am J Physiol 265: C834-C841, 1993
61. Crow MT, Kushmerick MJ: Chemical energetics of slow- and fast-twitch muscles of the mouse. J Gen Physiol 79: 147-166, 1982
62. Webster C, Silberstein L, Hays AP, Blau HM: Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy. Cell 52: 503-513, 1988
63. 2+. J Physiol 420: 337-353, 1990
64. Karpati G, Carpenter S, Prescott S: Small-caliber skeletal muscle fibers do not suffer necrosis in mdx mouse dystrophy. Muscle Nerve 11: 795-803, 1988
65. Maier A, Pette D: The time course of glycogen depletion in single fibers of chronically stimulated rabbit fast-twitch muscle. Plugers Arch 408: 338-342, 1987
66. Maier A, Gambke B, Pette D: Degeneration-regeneration as a mechanism contributing to the fast to slow conversion of chronically stimulated fast-twitch rabbit muscle. Cell Tissue Res 244: 635-643, 1986
67. McCully K, Shellock FG, Bank WJ, Posner JD: The use of nuclear magnetic resonance to evaluate muscle injury. Med Sci Sports Exerc 24: 537-542, 1992
68. McNeil PL, Khakee R: Disruptions of muscle fiber plasma membranes. Role in exercise-induced damage. Am J Pathol 140: 1097-1109, 1992
69. Steinhardt RA, Bi G, Alderton JM: Cell membrane resealing by a vesicular mechanism similar to neurotransmitter release. Science 263: 390-393, 1994
70. Vignos PJ, Watkins MP: The effect of exercise in muscular dystrophy. JAMA 197: 121-126, 1966
71. McCartney N, Moroz D, Garner SH, McComas AJ: The effects of strength training in patients with selected neuromuscular disorders. Med Sci Sports Exerc 20: 362-368, 1988
72. Hayes A, Lynch GS, Williams DA: The effects of endurance exercise on dystrophic mdx mice. I. Contractile and histochemical properties of intact muscles. Proc R Soc Lond Ser B 253: 19-25, 1993
73. Dupont-Versteegden EE, McCarter RJ, Katz MS: Voluntary exercise decreases progression of muscular dystrophy in diaphragm of mdx mice. J Appl Physiol 77(4): 1736-1741, 1994
74. Dick J, Vrbova G: Progressive deterioration of muscles in mdx mice induced by overload. Clin Sci 84: 145-150, 1993
75. Dimarco AF, Kelling JS, Dimarco MS, Jacobs I, Shields R, Altose MD: The effects of inspiratory resistive training on respiratory muscle function in patients with muscular dystrophy. Muscle Nerve 8: 284-290, 1985
76. Wanke T, Toifl K, Merkle M, Formanek D, Lahrmann H, Zwick H: Inspiratory muscle training in patients with Duchenne muscular dystrophy. Chest 105: 475-482, 1994
77. Smith PEM, Coakley JH, Edwards RHT: Respiratory muscle training in Duchenne muscular dystrophy. Muscle Nerve 11: 784-785, 1988
78. Scott OM, Hyde SA, Vrbova G, Dubowitz V: Therapeutic possibilities of chronic low frequency electrical stimulation in children with Duchenne muscular dystrophy. J Neurol Sci 95: 171-182, 1990
79. Gregoric M, Valencic V, Zupan A, Klemen A: Effects of electrical stimulation on muscles of patients with progressive muscular dystrophy. Amsterdam Excerpta Medica (Abstr.), 1988
80. Milner-Brown HS, Miller RG: Muscle strengthening through electric stimulation combined with low-resistance weights in patients with neuromuscular disorders. Arch Phys Med Rehab 69: 20-24, 1988
81. Zupan A: Long-term electrical stimulation of muscles in children with Duchenne and Becker muscular dystrophy. Muscle Nerve 15: 362-367, 1992
82. Dubowitz V, Hyde SA, Scott OM, Vrbova G: Effects of chronic high frequency stimulation on muscles of children with Duchenne muscular dystrophy. J Physiol 390: 132P, 1987
83. Coovert DD, Burghes AHM: Gene therapy for muscle diseases. Cur Op Neurol 7: 463-470, 1994
84. Ali M, Lemoine NR, Ring CJA: The use of DNA viruses as vectors for gene therapy. Gene Ther 1: 367-384, 1994
85. Deconinck N, Ragot T, Marechal G, Perricaudet M, Gillis JM: Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene. Proc Natl Acad Sci USA 93: 3570-3574, 1996
86. Ragot T, Vincent N, Chafey P, Vigne E, Gilgenkrantz H, Couton D, Cartaud J, Briand P, Kaplan JC, Perricaudet M, Kahn A: Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361: 647-650, 1993
87. Vincent N, Ragot T, Gilgenkrantz H, Couton D, Chafey P, Gregoire A, Briand P, Kaplan JC, Kahn A, Perricaudet M: Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nature Gene 5: 130-134, 1993
88. Acsadi G, Lochmuller H, Jani A, Huard J, Massie B, Prescott S, Simoneau M, Petrof BJ, Karpati G: Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer. Hum Gene Ther 7: 129-140, 1996
89. Petrof BJ, Acsadi G, Jani A, Massie B, Bourdon J, Matusiewicz N, Yang L, Lochmuller H, Karpati G: Efficiency and functional consequences of adenovirus-mediated in vivo gene transfer to normal and dystrophic (mdx) mouse diaphragm. Am J Respir Cell Mol Biol 13: 508-517, 1995
90. Yang Y, Nunes FA, Berencsi K, Furth EE, Gonczol E, Wilson JM: Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 91: 4407-4411, 1994
91. Tripathy SK, Goldwasser E, Lu M-M, Barr E, Leiden JM: Stable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus. Proc Natl Acad Sci USA 91: 11557-11561, 1994
92. Yang Y, Nunes FA, Berencsi K, Furth EE, Gonczol E, Wilson JM: Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 91: 4407-4411, 1994
93. Tripathy SK, Goldwasser E, Lu M-M, Barr E, Leiden JM: Stable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus. Proc Natl Acad Sci USA 91: 11557-11561, 1994